We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Exo2.0
Exosomes (topical) Research
Mostly mechanism / observationalLimited safety
7 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Exosomes (topical) studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2020–2026 with a typical study size of 28 participants.
Based on 7 studies · 2 RCTs · 83 total participants
Confidence
Low
By outcome
Skin healthPossible add-on improvement in facial aging when paired with microneedling/laser (experimental, unregulated; not a standalone effect) · 8-12 weeks
Mostly mechanism / observational3 studies
Hair & nails
Mostly mechanism / observational3 studies
Safety profile
Too few graded studies1 study
Wound & ulcer healing
Too few graded studies1 study
Active research area
6 studies in the last 5 years
20202026
1Systematic Review2025
Predictive models highlighted escalating risks linked to unregulated therapies (e.g. exosomes), while geospatial analysis revealed stark regional disparities.
Mixed-methods synthesis of 457 studies, 37,250 media articles, and regulatory databases (231,475 documented complications) on aesthetic-treatment safety
Predictive models specifically flagged escalating risks linked to unregulated therapies, naming exosomes as an example
Calls for mandatory adverse-event reporting and harmonized regulation — exosome aesthetics sit outside consistent oversight (mandatory safety counter-evidence)
Adipose tissue stem cell-derived exosomes-treated sides had achieved a significantly greater improvement than the control sides at the final follow-up visit (percentage reduction in échelle d'évaluation clinique des cicatrices d'acné scores: 32.5 vs 19.9%, p < 0.01).
Kwon HH, Yang SH, Lee J, Park BC, Park KY, Jung JY, Bae Y, Park GH. · Acta Derm Venereol (2020)
12-week double-blind split-face RCT (n=25): adipose-stem-cell exosome gel vs control gel, both after fractional CO2 laser
The exosome side showed significantly greater acne-scar improvement (32.5% vs 19.9% reduction, p<0.01) with milder erythema and shorter downtime
Exosomes were an adjuvant after laser resurfacing — the effect is inseparable from the laser procedure
The Global Aesthetic Improvement Scale score was significantly higher on the HACS-treated side than on the control side at the final follow-up visit (p = 0.005).
Park GH, Kwon HH, Seok J, Yang SH, Lee J, Park BC, Shin E, Park KY. · J Cosmet Dermatol (2023)
12-week randomized split-face study (n=28): microneedling + exosome solution vs microneedling + saline
The exosome side improved more on Global Aesthetic Improvement Scale (p=0.005), with greater gains in wrinkles, elasticity, hydration, and pigmentation
Both sides received microneedling, so the trial cannot separate the exosome benefit from the needling-induced collagen effect
Stem cell-derived exosomes can restore skin physiological function and regenerate or rejuvenate damaged skin tissue through various mechanisms such as decreased expression of matrix metalloproteinase (MMP), increased collagen and elastin production.
Hajialiasgary Najafabadi A, Soheilifar MH, Masoudi-Khoram N. · Cell Commun Signal (2024)
Review of exosome cargo (proteins, lipids, non-coding RNAs) and proposed anti-photoaging mechanisms
Proposed mechanisms: decreased matrix-metalloproteinase expression and increased fibroblast collagen/elastin production
Notes anti-aging effects are demonstrated mainly in in-vitro and preclinical studies, not robust human trials
There is scarce information on the use of platelet-rich plasma-derived exosomes in hair growth and skin rejuvenation. Isolation techniques, activation methods, and methods of delivery have not been optimized, which warrants further research.
Gupta AK, Wang T, Rapaport JA, Talukder M. · J Cosmet Dermatol (2025)
Most supportive evidence for platelet-rich-plasma exosomes is preclinical (animal wounds, in-vitro); human evidence is a single case study
Authors state evidence for hair growth and skin rejuvenation specifically is scarce
Isolation, activation, and delivery are not standardized — more research is needed (counter-evidence on standardization)
Additionally, their ability to modulate collagen production and remodeling underscores their potential in addressing skin aging and improving cosmetic outcomes.
Wang X, Wang W, Yao R, Liu Z, Wang Q. · Mol Cell Probes (2026)
20-year systematic review of stem-cell- and plant-derived exosomes across wound healing, skin aging, pigmentation, and hair loss
Frames exosome therapy as still bridging medical and aesthetic dermatology — promising potential rather than established practice
Several co-authors are affiliated with aesthetic-medicine clinics, relevant context for the optimistic framing
Trichoscopy assessments showed this treatment significantly increased terminal and vellus hair counts (P<0.0001) and decreased hair shedding on day 120 (P<0.01).
Ablon G. · J Drugs Dermatol (2025)
Open-label study (n=30): a stem-cell-derived exosome complex applied after RF microneedling on thinning-hair scalps
Significantly increased terminal/vellus hair counts and follicular density and reduced shedding by day 120; high satisfaction, no adverse events reported
Single-arm, manufacturer-branded, and combined with RF microneedling — no control for the needling effect or placebo/regression